Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 139
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Mechanisms suppressing noncoding translation

Mechanisms suppressing noncoding translation

 96

YTHDF2 regulates self non-coding RNA metabolism to control inflammation and tumorigenesis

YTHDF2 regulates self non-coding RNA metabolism to cont...

 51

Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome

 66